Therapeutic Drug Monitoring Market to Grow 7.4% CAGR and to Reach USD 2.55 billion by 2020

Therapeutic drug monitoring market projected to reach USD 2.55 billion by 2020 from USD 1.78 billion in 2015, growing at CAGR of 7.4% during forecast period (2015–2020). In this report, therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, & region.

Therapeutic drugs monitor market, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are major drivers for therapeutic drug monitoring market. Download Free Sample Papers Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=518398 .

Competitive landscape covers the various strategies adopted by industry players to maintain their position in the therapeutic drug monitoring market. The company profiles comprise the basic views on the key players in the therapeutic drug monitoring market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares.

Therapeutic Drug Monitoring Market, By Class of Drug
1 Introduction
2 Antiepileptic Drugs
3 Antiarrhythmic Drugs
4 Immunosuppressant Drugs
5 Antibiotic Drugs
6 Bronchodilator Drugs
7 Psychoactive Drugs

Therapeutic Drug Monitoring Market, By End User
1 Introduction
2 Hospital Laboratories
3 Commercial/Private Laboratories

Technological advances in tests used to monitor therapeutic drugs, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are the major drivers for the market.

Get More Information on Therapeutics Drug Monitoring Market with Top Trends and Company Profiles at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=518398 .

North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutics drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure.

Therapeutic Drug Monitoring Market, By Class of Drug
1 Introduction
2 Antiepileptics
3 Antiarrhythmic Drugs
4 Immunosuppressants
5 Antibiotics
6 Bronchodilators
7 Psychoactive Drugs

Major players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Danaher Corporation (U.S.).

Get Discount, Other Information on this study “Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020” research @ http://www.rnrmarketresearch.com/contacts/discount?rname=518398 .

The market in Europe on the other hand is growing at a slower rate as the healthcare sector is recovering from the economic downturn and the healthcare facilities are trying to minimize healthcare delivery costs. Growth in the APAC therapeutic drug monitoring market is comparatively slower due to the dearth of skilled healthcare personnel for performing therapeutic drug monitoring tests with minimal errors.

Contact:
sales@rnrmarketresearch.com / Call +1 888 391 5441
RnRMarketResearch Provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

Mr. Hrishikesh
Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

This release was published on openPR.